BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33951689)

  • 1. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Patients With Stage II to III Colorectal Cancer.
    Ahiko Y; Shida D; Nakamura Y; Imaizumi J; Takamizawa Y; Moritani K; Tsukamoto S; Kanemitsu Y
    Dis Colon Rectum; 2021 Oct; 64(10):1222-1231. PubMed ID: 33951689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Systemic Inflammation Indices by K-ras Status in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Akiyama T; Kato R; Sawayama H; Ogawa K; Yoshida N; Baba H
    Dis Colon Rectum; 2023 Aug; 66(8):e809-e817. PubMed ID: 35195557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Modifiable Lifestyle Factors and Postoperative Complications of Elective Surgery in Patients With Colorectal Cancer.
    Loogman L; de Nes LCF; Heil TC; Kok DEG; Winkels RM; Kampman E; de Wilt JHW; van Duijnhoven FJB; ;
    Dis Colon Rectum; 2021 Nov; 64(11):1342-1353. PubMed ID: 34082436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
    Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
    Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of CT Enterography Index for Postoperative Intra-abdominal Septic Complications in Patients With Crohn's Disease: Implications for Surgical Decision-Making.
    Wang K; Huang L; Huang W; Liu R; Chen X; Guo Z; Qian W; Yin Y; Li Y; Zhu W
    Dis Colon Rectum; 2021 Aug; 64(8):964-976. PubMed ID: 33951684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.
    Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
    Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
    Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
    Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Extramural Lymphatic, Vascular, and Perineural Invasion in Stage II Colon Cancer: A Comparison With Intramural Invasion.
    Cho SS; Park JW; Kang GH; Kim JH; Bae JM; Han SW; Kim TY; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2023 Mar; 66(3):366-373. PubMed ID: 35333785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients With Colorectal Cancer After Surgical Resection.
    Kusunoki K; Toiyama Y; Okugawa Y; Yamamoto A; Omura Y; Ohi M; Araki T; Kusunoki M
    Dis Colon Rectum; 2020 Sep; 63(9):1242-1250. PubMed ID: 33216495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High World Heath Organization Performance Status Is Associated With Short- and Long-term Outcomes After Colorectal Cancer Surgery: A Nationwide Population-Based Study.
    Bojesen RD; Degett TH; Dalton SO; Gögenur I
    Dis Colon Rectum; 2021 Jul; 64(7):851-860. PubMed ID: 34086001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
    Chang CY; Lin CC; Lin HH; Lan YT; Chang SC; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK
    Dis Colon Rectum; 2023 Oct; 66(10):e1032-e1042. PubMed ID: 36538674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Frailty Index Does Not Predict Risk of Postoperative Complications in Patients With IBD: A Multicenter Cohort Study.
    Rozich JJ; Zhao B; Luo J; Luo WY; Eisenstein S; Singh S;
    Dis Colon Rectum; 2023 Aug; 66(8):1085-1094. PubMed ID: 36622750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Survival in a Cohort of Patients Aged 75 Years and Older With Fecal Immunochemical Testing-Detected Colorectal Cancer.
    Cahill C; Lipson ME; Afzal AR; Maclean AR; Wong CK; Roen S; Buie WD
    Dis Colon Rectum; 2023 Apr; 66(4):511-520. PubMed ID: 35764093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients With Crohn's Disease.
    Yasuhara M; Beppu N; Uchino M; Ikeuchi H; Matsuda I; Hirota S; Ikeda M; Tomita N
    Dis Colon Rectum; 2021 Apr; 64(4):409-419. PubMed ID: 33394780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.